Montelukast Prescribing at DR MAHMOOD & PARTNERS
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
571
Total Quantity
12.5K
NHS Cost
£757
vs National Avg
-16.6%
DR MAHMOOD & PARTNERS prescribed 571 items of Montelukast over the last 12 months at a cost of £757 to the NHS. This is 16.6% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
43
Jun 2026
41
Jun 2026
54
Jun 2026
54
Jun 2026
47
Jun 2026
47
Jun 2026
46
Jun 2026
53
Jun 2026
52
Jun 2026
41
Jun 2026
45
Jun 2026
48
Prescribing Details
| Total Items | 571 |
|---|---|
| Total Quantity | 12,467 |
| Total NHS Cost | £757 |
| Presentations | 4 different forms |
| vs National Average | -16.6% |
Montelukast Prescribing Comparison
| This practice | 571 items |
|---|---|
| National average per practice | 685 items |
| Difference | -16.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.